FDA Inspection 857318 — Haupt Pharma Amareg GmbH

Haupt Pharma Amareg GmbH — FEI 3008293991

The FDA completed an inspection of Haupt Pharma Amareg GmbH on November 22, 2013 in Ratisbon. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 22, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ratisbon (Germany)